The following NCCTG cancer prevention/symptom management clinical trials are currently active. You may click on the trial number to link to a detailed description on PDQ, the National Cancer Institute's Web site for clinical trials.
| E5597 | Phase III Chemoprevention Trial of Selenium Supplementation in Persons With Resected Stage I Non-Small Cell Lung Cancer |
| N04C2 | An Exploratory, Randomized, Placebo-Controlled Trial of Depot Octreotide (Sandostatin LAR Depot ) for Symptomatic Ascites in Cancer Patients |
| N04CA | Pilocarpine for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study |
| N05C5 | A Phase III Randomized , Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome |
| N06C6 | A Phase III Randomized Trial of Cryoablation vs. Radiation for the Palliation of Painful Bone Metastases |
| N07C1 | A Phase III, Randomized, Double-Blind, Placebo-controlled Evaluation of Pregabalin for Alleviating Hot Flashes |
For more information, please discuss these trials with your physician, contact the NCCTG Operations Office or contact an NCCTG treating location near you.
Return to list of Cancer Prevention/Symptom Management Trials
© Copyright 2008, NCCTG